In March 2025, the company announced new strategies for a direct-to-customer supplying of its Wegovy weight loss drug. The company proven a whole new pharmacy, termed NovoCare, which would demand prospects $499 per month for entry to the drug, below 50 % the cost of the drug by means of other pharmaceutical distribution networks.[fifty three]Allerg